Clinical trial

Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to…

NCT00491933 · ASST Fatebenefratelli Sacco, Other · Unknown status

Key facts

NCT number NCT00491933
Title Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
Official title Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in the Assessment of Latent Mycobacterium Tuberculosis Infection in Patients Candidate to Treatment or Treated With TNFα Antagonists
Acronym TNFTB
Lead sponsor ASST Fatebenefratelli Sacco, Other
Status Unknown status
Study type Interventional
Conditions Rheumatoid Arthritis, Spondylarthritis, Tuberculosis
Intervention type Procedure
Interventions Quantiferon-TB Gold assay, Tuberculin skin test
Enrollment 100
Start date Jun 1, 2007
Completion Oct 1, 2007
First posted Jun 26, 2007
Last update posted Jun 26, 2007
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies